Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

15 Biggest Mid-Day Losers For Thursday

MMSI, CNC, QUIK, TNDM, RAVE, OEC, IDXG, PULM, RARE, SCPX, ATEC, CHMI

  • Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
  • Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
  • Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
  • Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
  • Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
  • QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
  • Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
  • Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and milestone obligations.
  • Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) declined 7.4 percent to $72.56 after the company reported topline data from Phase 2 UXOO7 study. The trial did not meet primary endpoint. PiperJaffray downgraded Ultragenyx Pharmaceutical from Overweight to Neutral.
  • Proofpoint Inc (NASDAQ: PFPT) shares declined 5.1 percent to $75.13. Goldman Sachs downgraded Proofpoint from Neutral to Sell.
  • Pulmatrix Inc (NASDAQ: PULM) shares fell 5.1 percent to $3.70 after rising 0.52 percent on Wednesday.
  • Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) fell 4.5 percent to $13.73. Bellicum Pharmaceuticals reported a proposed public offering of 5 million shares of common stock.
  • Cherry Hill Mortgage Investment Corp (NYSE: CHMI) declined 4.2 percent to $17.60 as the company reported a 4.5 million share offering.
  • Merit Medical Systems, Inc. (NASDAQ: MMSI) declined 4 percent to $28.42. Merit Medical priced 4.5 million share public offering of common stock at $28.25 per share.
  • Centene Corp (NYSE: CNC) shares fell 3.2 percent to $65.86. Citi downgraded Centene from Buy to Neutral.

Latest Ratings for CERU

Date Firm Action From To
Aug 2016 Barclays Maintains Overweight
Aug 2016 Wedbush Downgrades Outperform Neutral
Aug 2016 Leerink Swann Downgrades Outperform Market Perform

View More Analyst Ratings for CERU
View the Latest Analyst Ratings